Table of Contents
ISRN Gastroenterology
Volume 2012 (2012), Article ID 969015, 4 pages
http://dx.doi.org/10.5402/2012/969015
Research Article

Utility of Analgesic and Anxiolytic Medication Dose during Colonoscopy in Identifying Patients with Irritable Bowel Syndrome

1Medical Center Of Central Georgia, 777 Hemlock Street, Macon, GA 31201, USA
2Valley Gastroenterology Associates, 4860 McLeod Dr Ste A, Saginaw, MI 48604, USA
3Synergy Medical Education Alliance, 1000 Houghton Avenue, Saginaw, MI 48602, USA
4Synergy Medical Education Alliance, 1000 Houghton Avenue, Saginaw, MI 40602, USA

Received 28 September 2011; Accepted 27 October 2011

Academic Editor: W. A. Meier-Ruge

Copyright © 2012 Enoch Lule et al. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.

Linked References

  1. B. D. Cash, P. Schoenfeld, and W. D. Chey, “The utility of diagnostic tests in irritable bowel syndrome patients: a systematic review,” American Journal of Gastroenterology, vol. 97, no. 11, pp. 2812–2819, 2002. View at Google Scholar · View at Scopus
  2. D. A. Lieberman, J. Holub, G. Eisen, D. Kraemer, and C. D. Morris, “Utilization of colonoscopy in the United States: results from a national consortium,” Gastrointestinal Endoscopy, vol. 62, no. 6, pp. 875–883, 2005. View at Publisher · View at Google Scholar · View at PubMed
  3. A. J. Akhtar, M. A. Shaheen, and J. Zha, “Organic colonic lesions in patients with irritable bowel syndrome (IBS),” Medical Science Monitor, vol. 12, no. 9, pp. CR363–CR367, 2006. View at Google Scholar · View at Scopus
  4. A. Pironti, V. Tadeu, A. Pedroni et al., “Role of routine small intestinal biopsy in adult patient with irritable bowel syndrome-like symptoms,” Minerva Medica, vol. 101, no. 3, pp. 129–134, 2010. View at Google Scholar · View at Scopus
  5. H. Mertz, B. Naliboff, J. Munakata, N. Niazi, and E. A. Mayer, “Altered rectal perception is a biological marker of patients with irritable bowel syndrome,” Gastroenterology, vol. 109, no. 1, pp. 40–52, 1995. View at Publisher · View at Google Scholar · View at Scopus
  6. A. P. S. Hungin, L. Chang, G. R. Locke, E. H. Dennis, and V. Barghout, “Irritable bowel syndrome in the United States: prevalence, symptom patterns and impact,” Alimentary Pharmacology and Therapeutics, vol. 21, no. 11, pp. 1365–1375, 2005. View at Publisher · View at Google Scholar · View at PubMed · View at Scopus